About Clare Ozawa, Ph.D.
Form D filings for Kate Therapeutics in 2024 list Clare Ozawa, Ph.D. as director.
Clare Ozawa, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Clare Ozawa, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Clare Ozawa, Ph.D. works with at each company, as listed on that company's latest Form D.
Kate Therapeutics Inc. · Form D, Aug 7, 2024
KD
Kevin Forrest, Ph.D.
Chief Executive Officer and director
BD
Beth Seidenberg, M.D.
Director